跳至主要内容
临床试验/EUCTR2016-000082-23-NL
EUCTR2016-000082-23-NL进行中(未招募)不适用

Median Local Anaesthetic Dose (MLAD) of intrathecal Bupivacaine in total knee arthroplasty

Reinier de Graaf Groep0 个研究点开始时间: 2016年2月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • - ASA I, II or III
  • - 18 years or older
  • - primary total knee arthroplasty
  • - willing to participate
  • - sufficient command of Dutch
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Hypersensitivity to local anaesthetics or any of the other excipients of Bupivacaine
  • - Any other contraindications relate to intrathecal anaesthesia
  • - CNS disease, e.g. menigitis, tumor, poliomyelitis, cerebral haemorrhage
  • - Spinal stenosis and diseases or recent trauma to the cervical column
  • - Pernicious anemia with symptoms related to cervical degradation
  • - Pyogenic infections of the skin close to the injection site
  • - Cardiogenic or hypovolemic shock
  • - Disturbance in coagulation or treatment with anti-coagulants
  • - Patient is participating in a medicinal study
  • - Noncompliant with intrathecal anaesthesia
  • - No Local Infiltration Anaesthesia (LIA) possible
  • - Patients who are incompetent to decide

研究者

发起方
Reinier de Graaf Groep

相似试验